In an exclusive Managing IP podcast, Pfizer chief patent counsel Bryan Zielinski talks about his company’s patent operations and delves into the proposed COVID intellectual property waiver being discussed at the World Trade Organization.
He also discusses the important technologies that his company is working on and how his teams ensure they get sufficient patent protection, and even talks about the role artificial intelligence might play in future therapeutic discovery.
This is the first in a new podcast series brought to you by Managing IP. Click below to listen.
The material on this site is for law firms, companies and other IP specialists. It is for information only. Please read our Terms and Conditions and Privacy Notice before using the site. All material subject to strictly enforced copyright laws.
© 2021 Euromoney Institutional Investor PLC. For help please see our FAQs.